Longboard pharmaceuticals announces inducement grant under nasdaq listing rule 5635(c)(4)

La jolla, calif.--(business wire)---- $lbph #epilepsy--longboard pharmaceuticals, inc. (nasdaq: lbph), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today announced the grant of inducement awards to one new employee. the compensation committee of the board of directors of longboard approved the grant of non-qualified stock options to purchase an aggregate of 58,520 shares of its common stock (the “common stock”) as inducements material t.
LBPH Ratings Summary
LBPH Quant Ranking